Aller au contenu principal
Profil bibliographique

Jeffrey S. Crippin

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

130Publications signalées
7539Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Liver Disease Diagnosis and TreatmentOrgan Transplantation Techniques and OutcomesHepatitis C virus researchLiver Disease and TransplantationLiver Diseases and Immunity

Les publications récentes

Accès ouvert 2025 article OpenAlex

Clinical outcomes of COVID-19 infection in liver transplant recipients based on vaccination status

Vinathi Polamraju, Neeta A. Vachharajani, Brian F. Gage, Jeffrey S. Crippin et autres

Background COVID-19 disease burden has been mitigated by vaccination; however, concerns persist regarding weakened immune responses in liver transplant (LT) recipients. This study investigates COVID-19 outcomes in LT recipients based on vaccination status. Methods This single-center retrospective study identified LT recipients with …

us (code pays fourni par la source)

0 citations Frontiers in Transplantation
Accès ouvert 2023 article OpenAlex

Association of FDA Mandate Limiting Acetaminophen (Paracetamol) in Prescription Combination Opioid Products and Subsequent Hospitalizations and Acute Liver Failure

Babak John Orandi, Chandler McLeod, Paul A. MacLennan, William M. Lee et autres

Importance: In January 2011, the US Food and Drug Administration (FDA) announced a mandate to limit acetaminophen (paracetamol) to 325 mg/tablet in combination acetaminophen and opioid medications, with manufacturer compliance required by March 2014. Objective: To assess the odds of hospitalization and …

us, ca (code pays fourni par la source)

30 citations JAMA
Accès ouvert 2020 article OpenAlex

Liver transplantation for hepatitis C patients in the era of direct-acting antiviral treatment: A retrospective cohort study

Adeel S. Khan, Nathaniel Adams, Neeta A. Vachharajani, LeighAnne Dageforde et autres

INTRODUCTION: Direct-acting antivirals (DAA's) have revolutionized hepatitis-C virus (HCV) treatment, however controversy remains regarding timing of treatment in relation to liver-transplant (LT). METHODS: Single-center retrospective study assessing outcomes of listed HCV positive patients in the DAA-era (2014-2017). Patients treated with DAA's before …

us (code pays fourni par la source)

16 citations International Journal of Surgery

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.